75 related articles for article (PubMed ID: 19022326)
1. Functional assays are mandatory for a correct prediction of immunotoxic properties of compounds in vitro.
Koeper LM; Vohr HW
Food Chem Toxicol; 2009 Jan; 47(1):110-8. PubMed ID: 19022326
[TBL] [Abstract][Full Text] [Related]
2. Assessment of a new cell culture perfusion apparatus for in vitro chronic toxicity testing. Part 2: toxicological evaluation.
Jennings P; Koppelstaetter C; Pfaller W; Morin JP; Hartung T; Ryan MP
ALTEX; 2004; 21(2):61-6. PubMed ID: 15195226
[TBL] [Abstract][Full Text] [Related]
3. In vitro tests to evaluate immunotoxicity: a preliminary study.
Carfi' M; Gennari A; Malerba I; Corsini E; Pallardy M; Pieters R; Van Loveren H; Vohr HW; Hartung T; Gribaldo L
Toxicology; 2007 Jan; 229(1-2):11-22. PubMed ID: 17092623
[TBL] [Abstract][Full Text] [Related]
4. Disentangling cellular proliferation and differentiation in the embryonic stem cell test, and its impact on the experimental protocol.
van Dartel DA; Zeijen NJ; de la Fonteyne LJ; van Schooten FJ; Piersma AH
Reprod Toxicol; 2009 Sep; 28(2):254-61. PubMed ID: 19442486
[TBL] [Abstract][Full Text] [Related]
5. In vitro sensitivity of granulo-monocytic progenitors as a new toxicological cell system and endpoint in the ACuteTox Project.
Cerrato L; Valeri A; Bueren JA; Albella B
Toxicol Appl Pharmacol; 2009 Jul; 238(2):111-9. PubMed ID: 19442680
[TBL] [Abstract][Full Text] [Related]
6. Assessment of a new cell culture perfusion apparatus for in vitro chronic toxicity testing. Part 1: technical description.
Koppelstaetter C; Jennings P; Ryan MP; Morin JP; Hartung T; Pfaller W
ALTEX; 2004; 21(2):51-60. PubMed ID: 15195225
[TBL] [Abstract][Full Text] [Related]
7. Prediction of in vivo embryotoxic effect levels with a combination of in vitro studies and PBPK modelling.
Verwei M; van Burgsteden JA; Krul CA; van de Sandt JJ; Freidig AP
Toxicol Lett; 2006 Aug; 165(1):79-87. PubMed ID: 16517103
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the Vitotox and RadarScreen assays for the rapid assessment of genotoxicity in the early research phase of drug development.
Westerink WM; Stevenson JC; Lauwers A; Griffioen G; Horbach GJ; Schoonen WG
Mutat Res; 2009 May; 676(1-2):113-30. PubMed ID: 19393335
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of humoral response to allogeneic porcine mesenchymal stem cell with 12 days of tacrolimus.
Poncelet AJ; Nizet Y; Vercruysse J; Hiel AL; Saliez A; Gianello P
Transplantation; 2008 Dec; 86(11):1586-95. PubMed ID: 19077894
[TBL] [Abstract][Full Text] [Related]
10. Replacement of in vivo acute oral toxicity studies by in vitro cytotoxicity methods: opportunities, limits and regulatory status.
Ukelis U; Kramer PJ; Olejniczak K; Mueller SO
Regul Toxicol Pharmacol; 2008 Jun; 51(1):108-18. PubMed ID: 18362045
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and immunosuppressive activity of cyclolinopeptide A analogues containing homophenylalanine.
Drygała P; Olejnik J; Mazur A; Kierus K; Jankowski S; Zimecki M; Zabrocki J
Eur J Med Chem; 2009 Sep; 44(9):3731-8. PubMed ID: 19487056
[TBL] [Abstract][Full Text] [Related]
12. Tumor necrosis factor (TNF) receptor-2-mediated DNA synthesis and proliferation in primary cultures of adult rat hepatocytes: The involvement of endogenous transforming growth factor-alpha.
Okamoto H; Kimura M; Watanabe N; Ogihara M
Eur J Pharmacol; 2009 Feb; 604(1-3):12-9. PubMed ID: 19100731
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of high-throughput genotoxicity assays used in profiling the US EPA ToxCast chemicals.
Knight AW; Little S; Houck K; Dix D; Judson R; Richard A; McCarroll N; Akerman G; Yang C; Birrell L; Walmsley RM
Regul Toxicol Pharmacol; 2009 Nov; 55(2):188-99. PubMed ID: 19591892
[TBL] [Abstract][Full Text] [Related]
14. Use of Mishell-Dutton culture for the detection of the immunosuppressive effect of iron-containing compounds.
Ban M; Hettich D; Cavelier C
Toxicol Lett; 1995 Nov; 81(2-3):183-8. PubMed ID: 8553373
[TBL] [Abstract][Full Text] [Related]
15. Progress on the development of human in vitro dendritic cell based assays for assessment of the sensitizing potential of a compound.
dos Santos GG; Reinders J; Ouwehand K; Rustemeyer T; Scheper RJ; Gibbs S
Toxicol Appl Pharmacol; 2009 May; 236(3):372-82. PubMed ID: 19232364
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of a proposed in vitro test strategy using neuronal and non-neuronal cell systems for detecting neurotoxicity.
Gartlon J; Kinsner A; Bal-Price A; Coecke S; Clothier RH
Toxicol In Vitro; 2006 Dec; 20(8):1569-81. PubMed ID: 16959468
[TBL] [Abstract][Full Text] [Related]
17. A feasibility study developing an integrated testing strategy assessing skin irritation potential of chemicals.
Hoffmann S; Saliner AG; Patlewicz G; Eskes C; Zuang V; Worth AP
Toxicol Lett; 2008 Jul; 180(1):9-20. PubMed ID: 18585875
[TBL] [Abstract][Full Text] [Related]
18. Final amended report on the safety assessment of Methylparaben, Ethylparaben, Propylparaben, Isopropylparaben, Butylparaben, Isobutylparaben, and Benzylparaben as used in cosmetic products.
Int J Toxicol; 2008; 27 Suppl 4():1-82. PubMed ID: 19101832
[TBL] [Abstract][Full Text] [Related]
19. Ethyl methanesulfonate toxicity in Viracept--a comprehensive human risk assessment based on threshold data for genotoxicity.
Müller L; Gocke E; Lavé T; Pfister T
Toxicol Lett; 2009 Nov; 190(3):317-29. PubMed ID: 19443141
[TBL] [Abstract][Full Text] [Related]
20. An integrated approach to improved toxicity prediction for the safety assessment during preclinical drug development using Hep G2 cells.
Noor F; Niklas J; Müller-Vieira U; Heinzle E
Toxicol Appl Pharmacol; 2009 Jun; 237(2):221-31. PubMed ID: 19332084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
